Data from a very early-phase trial shows that the drug is safe and remains in the body for up to 56 weeks. From two ...
Lenacapavir' was developed by Gilead Sciences, a research-based biopharmaceutical company in the US, as a pre-exposure prophylaxis (PrEP) medication to prevent infection in people at risk of exposure ...
20mon MSN
It’s not yet known how many people have gotten sick in the Texas measles outbreak, but there are at least 215 confirmed cases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback